Australia's most trusted
source of pharma news
Wednesday, 23 October 2024
Posted 10 July 2024 AM
The chronic kidney disease market will more than quintuple in size over the coming decade, according to predictions from analyst GlobalData.
However, competition in the sector is fierce, and GlobalData warned new drugs needed a novel mechanism of action or an improvement on compliance to get included in patient treatments.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.